Alvim et al., 2016 - Google Patents
Weissella paramesenteroides WpK4 reduces gene expression of intestinal cytokines, and hepatic and splenic injuries in a murine model of typhoid feverAlvim et al., 2016
- Document ID
- 2555954771721168219
- Author
- Alvim L
- Sandes S
- Silva B
- Steinberg R
- Campos M
- Acurcio L
- Arantes R
- Nicoli J
- Neumann E
- Nunes A
- Publication year
- Publication venue
- Beneficial microbes
External Links
Snippet
Diarrhoea in piglets by Salmonella and other pathogens can be a serious health problem. Non-drug treatments such as probiotic microorganisms have various effects on the gastrointestinal microbiota dysbiosis and host immune system modulation. The aim of this …
- 241000192133 Weissella paramesenteroides 0 title abstract description 41
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—PROCESSES USING MICRO-ORGANISMS
- C12R1/00—Processes using micro-organisms
- C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
- C12R1/225—Lactobacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23Y—INDEXING SCHEME RELATING TO LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23Y2220/00—Lactobacillus
- A23Y2220/73—Rhamnosus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Alvim et al. | Weissella paramesenteroides WpK4 reduces gene expression of intestinal cytokines, and hepatic and splenic injuries in a murine model of typhoid fever | |
| García-Hernández et al. | Isolation, characterization and evaluation of probiotic lactic acid bacteria for potential use in animal production | |
| Victor et al. | Probiotic properties of lactobacilli strains isolated from raw cow milk in the western highlands of Cameroon | |
| Toscano et al. | A consumer’s guide for probiotics: 10 golden rules for a correct use | |
| Presti et al. | Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect | |
| De Sablet et al. | Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohemorrhagic Escherichia coli O157: H7 | |
| Espeche et al. | Lactic acid bacteria from raw milk as potentially beneficial strains to prevent bovine mastitis | |
| TWI401086B (en) | Lactobacillus plantarum and uses thereof | |
| Strompfová et al. | Selection of enterococci for potential canine probiotic additives | |
| Blajman et al. | In vitro and in vivo screening of native lactic acid bacteria toward their selection as a probiotic in broiler chickens | |
| Maia et al. | Evaluation of the components of a commercial probiotic in gnotobiotic mice experimentally challenged with Salmonella enterica subsp. enterica ser. Typhimurium | |
| JP6193858B2 (en) | Strains of lactic acid bacteria and / or bifidobacteria that inhibit / reduce growth of various biotypes of E. coli and various biotypes of Clostridium | |
| Silva et al. | In vitro assessment of functional properties of lactic acid bacteria isolated from faecal microbiota of healthy dogs for potential use as probiotics | |
| KR102517581B1 (en) | Probiotic and prebiotic compositions | |
| Zhang et al. | Screening and evaluation of lactic acid bacteria with probiotic potential from local Holstein raw milk | |
| JP2008538913A (en) | Probiotic compositions suitable for animals | |
| Lin et al. | Autochthonous lactic acid bacteria isolated from dairy cow feces exhibiting promising probiotic properties and in vitro antibacterial activity against foodborne pathogens in cattle | |
| Sadrani et al. | Screening of potential probiotic Lactobacillus strains isolated from fermented foods, fruits and of human origin | |
| Acurcio et al. | Milk fermented by Lactobacillus species from Brazilian artisanal cheese protect germ-free-mice against Salmonella Typhimurium infection | |
| Rastogi et al. | Selection of potential probiotic bacteria from exclusively breastfed infant faeces with antagonistic activity against multidrug-resistant ESKAPE pathogens | |
| Strompfová et al. | Lactobacilli and enterococci—potential probiotics for dogs | |
| US6841149B1 (en) | Probiotic mixture intended for monogastric animals to control intestinal flora populations | |
| KR102036275B1 (en) | A new Pediococcus acidilactici LDTM 5201 having advanced anti-inflammation(KCTC 13563BP) | |
| Jobby et al. | Exploring probiotic activity of Lactobacillus sp. isolated from indigenous breeds of cattle milk and fecal samples in Bhatan Village, MH., IN | |
| Alamdary et al. | Lactobacillus acidophilus attenuates toxin production by Vibrio cholerae and shigella dysenteriae following intestinal epithelial cells infection |